Pharmacokinetics of Rosuvastatin and Atorvastatin in Pediatric Dyslipidemia Patients: Clinical Impact of Genetic Variation in Statin Disposition
Phase of Trial: Phase I
Latest Information Update: 25 Jul 2017
At a glance
- Drugs Atorvastatin (Primary) ; Rosuvastatin (Primary)
- Indications Dyslipidaemias
- Focus Pharmacodynamics; Pharmacogenomic
- 18 Jul 2017 Planned End Date changed from 1 Jul 2017 to 1 Dec 2017.
- 18 Jul 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Dec 2017.
- 25 Feb 2015 New trial record